Characterization of 1577 Primary Prostate Cancers Reveals Novel Biological and Clinicopathologic Insights into Molecular Subtypes-Reference-Cited by-同舟云学术

Characterization of 1577 Primary Prostate Cancers Reveals Novel Biological and Clinicopathologic Insights into Molecular Subtypes

Published:2015-10 Issue:4 Volume:68 Page:555-567
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Tomlins Scott A.,Alshalalfa Mohammed,Davicioni Elai,Erho Nicholas,Yousefi Kasra,Zhao Shuang,Haddad Zaid,Den Robert B.,Dicker Adam P.,Trock Bruce J.,DeMarzo Angelo M.,Ross Ashley E.,Schaeffer Edward M.,Klein Eric A.,Magi-Galluzzi Cristina,Karnes R. Jeffrey,Jenkins Robert B.,Feng Felix Y.

Publisher

Elsevier BV

Subject

Urology

Reference46 articles.

1. Testing mutual exclusivity of ETS rearranged prostate cancer;Svensson;Lab Invest,2011

2. Common gene rearrangements in prostate cancer;Rubin;J Clin Oncol,2011

3. ETS rearrangements in prostate cancer;Rubin;Asian J Androl,2012

4. The prostate cancer genome: perspectives and potential;Barbieri;Urol Oncol Semin Orig Investig,2014

5. The role of SPINK1 in ETS rearrangement-negative prostate cancers;Tomlins;Cancer Cell,2008

Cited by 117 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular heterogeneity in prostate cancer and the role of targeted therapy;Life Sciences;2024-01

2. Molecular classifications of prostate cancer: basis for individualized risk stratification and precision therapy;Annals of Medicine;2023-11-08

3. Identification of modules and key genes associated with Breast Cancer subtypes through network analysis;2023-08-03

4. A harmonized resource of integrated prostate cancer clinical, -omic, and signature features;Scientific Data;2023-07-05

5. Phase II Randomized Study of Salvage Radiation Therapy Plus Enzalutamide or Placebo for High-Risk Prostate-Specific Antigen Recurrent Prostate Cancer After Radical Prostatectomy: The SALV-ENZA Trial;Journal of Clinical Oncology;2023-02-20